Home › Compare › ENMHF vs MRK

ENMHF vs MRK: Dividend Comparison 2026

ENMHF yields 5000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ENMHF wins by $62217131802825.30M in total portfolio value
10 years
ENMHF
ENMHF
● Live price
5000.00%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62217131802825.35M
Annual income
$59,861,980,287,378,210,000.00
Full ENMHF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ENMHF vs MRK

📍 ENMHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodENMHFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ENMHF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ENMHF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ENMHF
Annual income on $10K today (after 15% tax)
$425,000.00/yr
After 10yr DRIP, annual income (after tax)
$50,882,683,244,271,480,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ENMHF beats the other by $50,882,683,244,271,470,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ENMHF + MRK for your $10,000?

ENMHF: 50%MRK: 50%
100% MRK50/50100% ENMHF
Portfolio after 10yr
$31108565901412.70M
Annual income
$29,930,990,143,689,110,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ENMHF
No analyst data
Altman Z
29.8
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ENMHF buys
0
MRK buys
0
No recent congressional trades found for ENMHF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricENMHFMRK
Forward yield5000.00% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$62217131802825.35M ✓$56.8K
Annual income after 10y$59,861,980,287,378,210,000.00 ✓$9,798.13
Total dividends collected$62057786341622.61M ✓$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ENMHF vs MRK ($10,000, DRIP)

YearENMHF PortfolioENMHF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$510,700$500,000.00$11,206$366.19+$499.5K → ENMHF
2$24,410,935$23,864,485.98$12,650$502.35+$24.40M → ENMHF
3$1,092,192,501$1,066,072,800.30$14,407$694.19+$1092.18M → ENMHF
4$45,746,366,951$44,577,720,975.17$16,585$967.82+$45746.35M → ENMHF
5$1,793,932,828,410$1,744,984,215,772.56$19,342$1,363.89+$1793932.81M → ENMHF
6$65,871,973,805,320$63,952,465,678,921.49$22,913$1,947.19+$65871973.78M → ENMHF
7$2,265,146,887,602,700$2,194,663,875,631,007.20$27,662$2,823.89+$2265146887.58M → ENMHF
8$72,954,689,148,998,180$70,530,981,979,263,280.00$34,159$4,173.35+$72954689148.96M → ENMHF
9$2,201,076,182,660,884,700$2,123,014,665,271,456,500.00$43,337$6,308.80+$2201076182660.84M → ENMHF
10$62,217,131,802,825,350,000$59,861,980,287,378,210,000.00$56,776$9,798.13+$62217131802825.30M → ENMHF

ENMHF vs MRK: Complete Analysis 2026

ENMHF — Stock

ENM Holdings Limited, an investment holding company, engages in the retail of fashion wear and accessories. It operates through three segments: Retail of Fashion Wear and Accessories; Resort and Recreational Club Operations; and Investments. The company operates a chain of multi-label stores, as well as mono-brand boutiques under The Swank brand in Hong Kong and China; and Hilltop Country Club that provides conferences, dining, lodging, recreational, and outdoor activities for its members in Hong Kong, as well as offers menswear fashion products under the Cesare di Pino brand name. It also holds and trades in investments for short term and long term investment returns. The company was formerly known as e-New Media Company Limited and changed its name to ENM Holdings Limited in June 2005. ENM Holdings Limited was incorporated in 1966 and is based in Tsuen Wan, Hong Kong.

Full ENMHF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ENMHF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ENMHF vs SCHDENMHF vs JEPIENMHF vs OENMHF vs KOENMHF vs MAINENMHF vs JNJENMHF vs ABBVENMHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.